Related Experiment Video

Updated: May 15, 2026

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

Oral propranolol for treatment of pediatric capillary hemangiomas

Maryam Aletaha1, Hossein Salour, Abbas Bagheri

  • 1Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Journal of Ophthalmic & Vision Research
|January 1, 2013
PubMed

Insights

Oral propranolol effectively treats pediatric capillary hemangiomas, showing significant improvement within two months. This study indicates propranolol is a safe and effective first-line treatment for these common childhood vascular lesions.

Area of Science:

  • Pediatric Dermatology
  • Ophthalmology
  • Pharmacology

Background:

  • Capillary hemangiomas are common benign vascular tumors in infants.
  • Periocular hemangiomas can cause significant visual impairment and cosmetic concerns.
  • Limited effective and safe treatment options have historically been available.

Purpose of the Study:

  • To evaluate the long-term efficacy and safety of oral propranolol for treating pediatric periocular capillary hemangiomas.
  • To assess the treatment response and potential complications associated with propranolol therapy.

Main Methods:

  • Three infants with periocular capillary hemangiomas were treated with oral propranolol (2-3 mg/kg/day).
  • Treatment was administered for up to one year of age, followed by a gradual taper.
  • Infants were monitored for 20 months to assess lesion evolution and treatment outcomes.

Main Results:

  • All patients demonstrated significant improvement within the first two months of therapy.
  • A continuous and slow positive effect was observed throughout the 20-month follow-up period.
  • No serious adverse complications were reported during the treatment course.

Conclusions:

  • Oral propranolol is a safe and effective first-line treatment for pediatric capillary hemangiomas.
  • The drug facilitates rapid and sustained regression of these vascular lesions.
  • Propranolol offers a promising therapeutic option for improving outcomes in affected children.
Abstract

Keywords:
Capillary HemangiomaOral Propranolol

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...